Britni Shrout|
Kyle Kniepman joined the MJ team as an employee benefits consultant in our Benefits Consulting department. In his role, Kyle proactively drives sales and services to new and existing clients by understanding their unique business needs, identifying potential solutions, and developing innovative healthcare and benefit strategies.
Kyle previously served as a business development executive specializing in the large market segment of 300+ at Blue Cross Blue Shield of Arizona. In this capacity, Kyle’s responsibilities encompassed identifying potential healthcare business customers, as well as expanding and diversifying Blue Cross Blue Shield’s clientele. By leveraging his specialized industry experience, Kyle brings a wealth of knowledge to our clients, designing customized and effective strategies that work for each unique client need.
Related Blogs
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn DeckThe Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
Adam AdlerFor years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Chris AntypasVolatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
White House Launches TrumpRx, Unveils Drug Prices
DeAnn DeckOn Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More
DOL Issues Updated Model Employer CHIP Notice
DeAnn DeckThe U.S. Department of Labor (DOL), through its Employee Benefits Security Administration (EBSA), has released a new model Employer CHIP Notice with information current ...
Read More
Prescription Drug Reporting (RxDC Report)
DeAnn DeckThe No Surprises Act (NSA), enacted as part of the Consolidated Appropriations Act, 2021 (CAA), includes transparency provisions requiring group health plans to report ...
Read More